SCNI
Scinai Immunotherapeutics
SCNI
SCNI
3 hedge funds and large institutions have $118K invested in Scinai Immunotherapeutics in 2016 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
–
Holders Change %
0%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$5K |
Top Sellers
| 1 |
TRCT
1
Tower Research Capital (TRC)
New York
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
VIA
1
Vantage Investment Advisors
State College,
Pennsylvania
| $60K | – | – | – |
|
2
Bank of Montreal
Toronto,
Ontario, Canada
| $53K | – | – | – |
|
|
3
UBS Group
Zurich,
Switzerland
| $5K | +$5K | +14 | New |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| – | -$3K | -8 | Closed |
|